PL3235494T3 - Preparat transdermalny zawierający donepezil jako składnik aktywny - Google Patents
Preparat transdermalny zawierający donepezil jako składnik aktywnyInfo
- Publication number
- PL3235494T3 PL3235494T3 PL15870365T PL15870365T PL3235494T3 PL 3235494 T3 PL3235494 T3 PL 3235494T3 PL 15870365 T PL15870365 T PL 15870365T PL 15870365 T PL15870365 T PL 15870365T PL 3235494 T3 PL3235494 T3 PL 3235494T3
- Authority
- PL
- Poland
- Prior art keywords
- active ingredient
- preparation containing
- transdermal preparation
- containing donepezil
- donepezil
- Prior art date
Links
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 title 2
- 239000004480 active ingredient Substances 0.000 title 1
- 229960003530 donepezil Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20140183446 | 2014-12-18 | ||
| EP15870365.2A EP3235494B1 (en) | 2014-12-18 | 2015-12-18 | Transdermal preparation containing donepezil as active ingredient |
| PCT/KR2015/013940 WO2016099198A1 (ko) | 2014-12-18 | 2015-12-18 | 도네페질을 유효성분으로 함유하는 경피흡수제제 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3235494T3 true PL3235494T3 (pl) | 2020-08-24 |
Family
ID=56126987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15870365T PL3235494T3 (pl) | 2014-12-18 | 2015-12-18 | Preparat transdermalny zawierający donepezil jako składnik aktywny |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10888533B2 (pl) |
| EP (1) | EP3235494B1 (pl) |
| JP (1) | JP6793648B2 (pl) |
| KR (1) | KR101796771B1 (pl) |
| CN (2) | CN113797180A (pl) |
| AU (1) | AU2015363883B2 (pl) |
| CA (1) | CA2970276C (pl) |
| DK (1) | DK3235494T3 (pl) |
| ES (1) | ES2786399T3 (pl) |
| HU (1) | HUE048569T2 (pl) |
| MY (1) | MY181540A (pl) |
| PL (1) | PL3235494T3 (pl) |
| PT (1) | PT3235494T (pl) |
| RU (1) | RU2713207C2 (pl) |
| WO (1) | WO2016099198A1 (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201805570WA (en) | 2015-12-30 | 2018-07-30 | Corium Int Inc | Systems and methods for long term transdermal administration |
| WO2017223402A1 (en) | 2016-06-23 | 2017-12-28 | Corium International, Inc. | Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent |
| AU2017301928B2 (en) | 2016-07-27 | 2023-04-06 | Corium, LLC. | Donepezil transdermal delivery system |
| CA3031944A1 (en) | 2016-07-27 | 2018-02-01 | Corium International, Inc. | Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery |
| US10945968B2 (en) | 2016-07-27 | 2021-03-16 | Corium, Inc. | Memantine transdermal delivery systems |
| KR102033686B1 (ko) | 2017-05-19 | 2019-10-18 | 보령제약 주식회사 | 도네페질을 함유하는 마이크로니들 경피 패치 |
| EP3658127A1 (en) * | 2017-07-26 | 2020-06-03 | Corium, Inc. | Transdermal delivery system with a microporous membrane having solvent-filled pores |
| US11173132B2 (en) | 2017-12-20 | 2021-11-16 | Corium, Inc. | Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point |
| KR102024996B1 (ko) * | 2017-12-27 | 2019-09-25 | 동아에스티 주식회사 | 도네페질을 함유하는 치매 치료용 경피흡수제제 |
| KR102115102B1 (ko) | 2018-12-21 | 2020-05-26 | 동아에스티 주식회사 | 안정화된 도네페질 함유 경피 흡수제제 |
| KR102709239B1 (ko) | 2021-10-20 | 2024-09-25 | 서울대학교병원 | 치매 약물의 부작용을 평가할 수 있는 치매 약물 패치 |
| KR20240146479A (ko) * | 2023-03-29 | 2024-10-08 | 아이큐어 주식회사 | 고용량 도네페질 약물탑재 지속방출 경피흡수제제 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5985317A (en) * | 1996-09-06 | 1999-11-16 | Theratech, Inc. | Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents |
| JP3987655B2 (ja) | 1998-03-03 | 2007-10-10 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 抗痴呆薬を含有した経皮適用製剤又は坐剤 |
| CN1250206C (zh) * | 2001-03-07 | 2006-04-12 | 久光制药株式会社 | 贴剂 |
| EP1437130A4 (en) | 2001-10-17 | 2009-08-26 | Hisamitsu Pharmaceutical Co | PERCUTANEOUS ABSORPTION PREPARATIONS |
| KR101408454B1 (ko) * | 2006-12-01 | 2014-06-17 | 닛토덴코 가부시키가이샤 | 도네페질 함유 접착 제제의 착색을 억제하는 방법 및 도네페질의 친척 물질의 생성량을 감소시키는 방법 |
| KR101454362B1 (ko) * | 2008-03-24 | 2014-10-23 | 아이큐어 주식회사 | 도네페질을 유효성분으로 함유하는 치매 치료용경피흡수제제 |
| US20090291127A1 (en) * | 2008-05-21 | 2009-11-26 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
| WO2010039381A1 (en) * | 2008-09-30 | 2010-04-08 | Teikoku Pharma Usa, Inc. | Transdermal extended-delivery donepezil compositions and methods for using the same |
| US8456368B2 (en) * | 2009-01-27 | 2013-06-04 | Casio Computer Co., Ltd. | Antenna device and radio-wave receiver with such antenna device |
| US20100209484A1 (en) * | 2009-02-13 | 2010-08-19 | Hoo-Kyun Choi | Transdermal Triptan Delivery System |
| WO2011034323A2 (en) * | 2009-09-16 | 2011-03-24 | Samyang Corporation | Transdermal delivery system, method for manufacturing the same, and transdermal delivery method using the system |
| JP2012236773A (ja) * | 2009-12-16 | 2012-12-06 | Goto Takeshi | 抗認知症薬物の経皮吸収製剤 |
| US20100178307A1 (en) * | 2010-01-13 | 2010-07-15 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
| NZ605352A (en) * | 2010-06-30 | 2013-10-25 | Nal Pharmaceuticals Ltd | Process for producing glycosaminoglycans |
| TWI433904B (zh) * | 2011-01-12 | 2014-04-11 | Taiwan Biotech Co Ltd | 多奈哌齊經皮貼片 |
| KR101395557B1 (ko) * | 2011-08-25 | 2014-05-16 | 아이큐어 주식회사 | 경피 흡수 제제 및 그 제조방법 |
| KR101239150B1 (ko) | 2012-02-28 | 2013-03-06 | 에스케이케미칼주식회사 | 도네페질-함유 경피흡수제제 및 그의 제조방법 |
| US9539201B2 (en) * | 2012-04-20 | 2017-01-10 | KAT Transdermals LLC | Selegiline transdermal system |
| CN102895217A (zh) * | 2012-11-13 | 2013-01-30 | 沈阳药科大学 | 长效多奈哌齐经皮吸收贴剂 |
| KR101770675B1 (ko) * | 2013-01-30 | 2017-08-23 | 에스케이케미칼주식회사 | 도네페질-함유 경피흡수제제 및 그의 제조방법 |
| CN108123793A (zh) * | 2017-12-19 | 2018-06-05 | 杭州中天微系统有限公司 | 基于apb总线的spi通信装置 |
-
2015
- 2015-12-18 DK DK15870365.2T patent/DK3235494T3/da active
- 2015-12-18 EP EP15870365.2A patent/EP3235494B1/en active Active
- 2015-12-18 WO PCT/KR2015/013940 patent/WO2016099198A1/ko not_active Ceased
- 2015-12-18 PT PT158703652T patent/PT3235494T/pt unknown
- 2015-12-18 CN CN202111197382.8A patent/CN113797180A/zh active Pending
- 2015-12-18 CA CA2970276A patent/CA2970276C/en active Active
- 2015-12-18 KR KR1020150181809A patent/KR101796771B1/ko active Active
- 2015-12-18 JP JP2017533482A patent/JP6793648B2/ja active Active
- 2015-12-18 CN CN201580069780.8A patent/CN107106510A/zh active Pending
- 2015-12-18 RU RU2017125361A patent/RU2713207C2/ru active
- 2015-12-18 ES ES15870365T patent/ES2786399T3/es active Active
- 2015-12-18 HU HUE15870365A patent/HUE048569T2/hu unknown
- 2015-12-18 AU AU2015363883A patent/AU2015363883B2/en active Active
- 2015-12-18 PL PL15870365T patent/PL3235494T3/pl unknown
- 2015-12-18 MY MYPI2017702165A patent/MY181540A/en unknown
-
2017
- 2017-06-16 US US15/625,054 patent/US10888533B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR101796771B1 (ko) | 2017-11-10 |
| EP3235494A1 (en) | 2017-10-25 |
| CA2970276A1 (en) | 2016-06-23 |
| AU2015363883B2 (en) | 2021-03-25 |
| EP3235494A4 (en) | 2018-08-15 |
| KR20160074433A (ko) | 2016-06-28 |
| ES2786399T3 (es) | 2020-10-09 |
| BR112017012951A2 (pt) | 2018-03-06 |
| RU2017125361A3 (pl) | 2019-07-17 |
| CN107106510A (zh) | 2017-08-29 |
| DK3235494T3 (da) | 2020-03-02 |
| CA2970276C (en) | 2023-08-01 |
| RU2017125361A (ru) | 2019-01-18 |
| HUE048569T2 (hu) | 2020-07-28 |
| JP6793648B2 (ja) | 2020-12-02 |
| CN113797180A (zh) | 2021-12-17 |
| US10888533B2 (en) | 2021-01-12 |
| US20170290780A1 (en) | 2017-10-12 |
| PT3235494T (pt) | 2020-03-05 |
| MY181540A (en) | 2020-12-28 |
| JP2017538771A (ja) | 2017-12-28 |
| WO2016099198A1 (ko) | 2016-06-23 |
| RU2713207C2 (ru) | 2020-02-04 |
| AU2015363883A1 (en) | 2017-06-29 |
| EP3235494B1 (en) | 2019-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3235494T (pt) | Preparação transdérmica contendo donepezilo como ingrediente ativo | |
| IL253123B (en) | Preparations for administration through the skin and their uses | |
| IL248984A0 (en) | Transdermal cream | |
| IL252550A0 (en) | Cannabinoid compounds through the skin | |
| ZA201605855B (en) | Agrochemical composition for foliage treatment | |
| GB201516729D0 (en) | Liquid nicotine formulation | |
| SG11201702298VA (en) | Pharmaceutical preparation | |
| IL252062A0 (en) | Transdermal compositions | |
| EP3096745A4 (en) | Transdermal delivery system comprising donepezil or its salt | |
| SG11201605366QA (en) | Pharmaceutical composition containing pyridylaminoacetic acidcompound | |
| IL251059B (en) | Arimoclomol formulation | |
| IL273087A (en) | Transdermal compositions | |
| SG11201610636VA (en) | Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor | |
| PL3184492T3 (pl) | Preparat antyseptyczny | |
| IL249010A0 (en) | A pharmaceutical preparation containing a pyrazine carboxamide compound as an active ingredient | |
| SG11201608845PA (en) | Cosmetic composition containing mentha haplocalyx as active ingredient | |
| EP3100721A4 (en) | Capsule formulation | |
| EP3107532A4 (en) | Transdermal drug delivery system containing donepezil | |
| IL258675A (en) | Mosquito repellent compounds | |
| EP3181125A4 (en) | Capsule formulation | |
| IL258295A (en) | Fviii formulation | |
| EP3299012A4 (en) | Transdermal liquid preparation | |
| EP3150205A4 (en) | Transdermal preparation | |
| ZA201500995B (en) | Low dose pharmaceutical composition | |
| GB201417589D0 (en) | Pharmaceutical Formulations |